Prognosis of Patients with Hodgkin Lymphoma and Indeterminate Response to PD-1 Inhibitor Therapy: Considerations for Application of LYRIC Criteria in Real Clinical Practice
ANNALS OF HEMATOLOGY（2024）
Key words
Hodgkin lymphoma,Relapsed and refractory disease,PD-1 inhibitors,Nivolumab,Indeterminate response,LYRIC criteria,Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined